Long‐term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|20|3709-3716

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.20, 2015-10, pp. : 3709-3716

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic Graft versus Host Disease but not the Intensity of Conditioning has Impact on Survival after Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Hematological Diseases

By  

Oncology Research and Treatment, Vol. 35, Iss. 9, 2012-08 ,pp. : 487-492

Karger

Access to resources Recommend Favorite

Erythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long‐term survival

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 9, 2015-09 ,pp. : E197-E199

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Implications of Minimal Residual Disease Monitoring for Stem Cell Transplantation after Reduced Intensity and Nonmyeloablative Conditioning

By  

Acta Haematologica, Vol. 112, Iss. 1-2, 2004-06 ,pp. : 93-104

Karger

Access to resources Recommend Favorite

Oral cyclosporine A treatment is feasible after myeloablative conditioning in allogeneic hematopoietic stem cell transplantation

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 40, Iss. 3, 2015-06 ,pp. : 358-361

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation

By  

Case Reports in Oncology, Vol. 5, Iss. 1, 2012-02 ,pp. : 110-113

Karger

Access to resources Recommend Favorite